Radiopharm Theranostics Limited
RADX - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$35.45K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $35,451.00 |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $-4.56 |
| Beta | 0.8 |
| Outstanding Shares | 39,390 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -0.32 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Last Earnings Call
Report Date
August 28, 2026
EPS Estimate
$-1.67
Consensus analyst estimateRevenue Estimate
$845,235
Consensus analyst estimateNext Earnings Call
Expected Date
February 26, 2027
EPS Estimate
$-1.05
Consensus analyst estimateRevenue Estimate
$699,250
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 129792.68%▲ 129358.39% |
|---|---|
| Total Invested | $1.19M▼ 42.41% |
| Investors Holding | 70% |
About Radiopharm Theranostics Limited
14 employees
CEO: Riccardo Canevari
Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company d...